(TSU) Trisura - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA89679A2092

TSU: Insurance, Bonds, Reinsurance, Surety, Contracts

Trisura Group Ltd. is a specialty insurance company with a focused portfolio across surety, risk solutions, corporate insurance, and reinsurance. Operating primarily in Canada and the United States, the company has built a niche in serving construction, manufacturing, and service contractors through its contract surety bonds, which include performance and labor/material payment bonds. These bonds are critical for ensuring project completion and payment security in high-stakes industries.

Through its U.S. and Canadian segments, Trisura offers a range of risk solutions, fronting services, and specialized insurance products. The company’s commercial surety bonds cater to federal and state courts, government entities, financial institutions, and private corporations, addressing the need for security in legal and financial transactions. This diversification allows Trisura to maintain a balanced risk profile while capitalizing on growth opportunities in both mature and specialized insurance markets.

Founded in 2017 and headquartered in Toronto, Trisura has quickly established itself as a player in the North American specialty insurance space. With a market capitalization of CAD 1.72 billion, the company trades at a P/E ratio of 14.77, with a forward P/E of 11.99, suggesting investor expectations of future earnings growth. Its price-to-book ratio of 2.19 reflects the market’s valuation of its balance sheet strength, while the price-to-sales ratio of 0.54 indicates a potential undervaluation relative to its revenue generation.

Trisura’s focus on underwriting discipline and risk management has positioned it well to navigate the complexities of the specialty insurance market. Its ability to provide tailored solutions for contractors, corporations, and government entities underscores its strategic relevance in a sector where trust, reliability, and financial stability are paramount. For investors, Trisura’s combination of a diversified product portfolio, geographic reach, and financial stability makes it a compelling option in the property and casualty insurance space.

Additional Sources for TSU Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

TSU Stock Overview

Market Cap in USD 1,114m
Sector Financial Services
Industry Insurance - Specialty
GiC Sub-Industry Property & Casualty Insurance
IPO / Inception

TSU Stock Ratings

Growth 5y 41.4%
Fundamental 59.4%
Dividend 0.0%
Rel. Strength -29
Analysts -
Fair Price Momentum 32.88 CAD
Fair Price DCF 52.43 CAD

TSU Dividends

No Dividends Paid

TSU Growth Ratios

Growth Correlation 3m -71.4%
Growth Correlation 12m -72.4%
Growth Correlation 5y 43.7%
CAGR 5y 30.68%
CAGR/Max DD 5y 0.77
Sharpe Ratio 12m -0.65
Alpha -21.73
Beta 0.779
Volatility 30.56%
Current Volume 145.1k
Average Volume 20d 93.8k
What is the price of TSU stocks?
As of April 02, 2025, the stock is trading at CAD 35.54 with a total of 145,072 shares traded.
Over the past week, the price has changed by +8.42%, over one month by +6.47%, over three months by -6.55% and over the past year by -14.30%.
Is Trisura a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Trisura (TO:TSU) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 59.40 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TSU as of April 2025 is 32.88. This means that TSU is currently overvalued and has a potential downside of -7.48%.
Is TSU a buy, sell or hold?
Trisura has no consensus analysts rating.
What are the forecast for TSU stock price target?
According to ValueRays Forecast Model, TSU Trisura will be worth about 36.7 in April 2026. The stock is currently trading at 35.54. This means that the stock has a potential upside of +3.18%.
Issuer Forecast Upside
Wallstreet Target Price 50.4 41.9%
Analysts Target Price - -
ValueRay Target Price 36.7 3.2%